Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Oncolytics Biotech declining 23%. In contrast, Reunion Neuroscience has gained 59%. This takes the industry's 12 month performance to a gain of 28%. Looking forward, earnings are forecast to grow by 48% annually.
Has the Canadian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|
How does Canadian Biotech compare with similar industries?
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REUN Reunion Neuroscience | CA$1.51 | 58.9% +CA$6.6m | -73.3% | PS3.6x | |
MSCL Satellos Bioscience | CA$0.60 | 9.1% +CA$5.6m | -18.9% | PB31.8x | |
MDNA Medicenna Therapeutics | CA$0.79 | 9.7% +CA$4.9m | -33.1% | PB1.7x | |
IBT IBEX Technologies | CA$1.00 | 22.0% +CA$4.5m | 110.5% | PE17.9x | |
QPT Quest PharmaTech | CA$0.10 | 33.3% +CA$4.2m | -28.6% | PB0.2x |